BRCA

According to new research headed by University College London experts existing drugs that affect the impact of the hormone progesterone, such as mifepristone, have been found to reduce the risk of severe triple negative breast cancer in women with a BRCA1 gene mutation. In premenopausal women, breast cancer is the main cause of death. Progesterone…